Effect of del nido cardioplegia use on kidney injury after coronary bypass operations

Detalhes bibliográficos
Autor(a) principal: Kağan AS,Ahmet
Data de Publicação: 2021
Outros Autores: Engin,Mesut, Amaç,Bişar, Aydın,Ufuk, Eriş,Cüneyt, Ata,Yusuf, Türk,Tamer
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Revista da Associação Médica Brasileira (Online)
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302021001001322
Resumo: SUMMARY OBJECTIVE: After cardiac surgery, acute kidney injury is observed at a rate of 5–30%, and the second most common cause of acute kidney injury in intensive care units is cardiac surgery. In this study, we aimed to investigate the effect of del Nido cardioplegia solution use on postoperative acute kidney injury development in patients who underwent coronary artery bypass grafting operation with cardiopulmonary bypass. METHODS: Consecutive patients who underwent an elective coronary artery bypass grafting operation with cardiopulmonary bypass in our clinic between March 15, 2019, and March 15, 2020, were included in the study retrospectively. The patients were divided into two groups as those who received del Nido cardioplegia solution (Group 1) and blood cardioplegia (Group 2), and factors affecting the development of renal failure were examined. RESULTS: A total of 350 consecutive patients were included in the study. There were 156 patients in the del Nido cardioplegia group and 194 patients in the blood cardioplegia group. Among the patient group, 74 (21.1%) patients developed acute kidney injury. The total acute kidney injury development rate was significantly higher in Group 2 (p=0.018). In multivariate logistic regression analysis, advanced age (OR 1.128; 95%CI 1.044–1.217; p=0.042), increased blood product use (OR 1.318; 95%CI 1.154–1.998; p=0.019), preoperative creatinine elevation (OR 2.434; 95%CI 1.655–4.639; p=0.005), and increased cardioplegia volume (OR 1.254; 95%CI 1.109–2.980; p=0.009) were independent predictors of acute kidney injury. CONCLUSION: With this study, we showed that the use of del Nido cardioplegia solution can reduce the incidence of acute kidney injury.
id AMB-1_c5101f7c587e2c4f479474313e0bdc0d
oai_identifier_str oai:scielo:S0104-42302021001001322
network_acronym_str AMB-1
network_name_str Revista da Associação Médica Brasileira (Online)
repository_id_str
spelling Effect of del nido cardioplegia use on kidney injury after coronary bypass operationsCoronary artery bypass surgeryCardiopulmonary bypassKidneyCardioplegiaSUMMARY OBJECTIVE: After cardiac surgery, acute kidney injury is observed at a rate of 5–30%, and the second most common cause of acute kidney injury in intensive care units is cardiac surgery. In this study, we aimed to investigate the effect of del Nido cardioplegia solution use on postoperative acute kidney injury development in patients who underwent coronary artery bypass grafting operation with cardiopulmonary bypass. METHODS: Consecutive patients who underwent an elective coronary artery bypass grafting operation with cardiopulmonary bypass in our clinic between March 15, 2019, and March 15, 2020, were included in the study retrospectively. The patients were divided into two groups as those who received del Nido cardioplegia solution (Group 1) and blood cardioplegia (Group 2), and factors affecting the development of renal failure were examined. RESULTS: A total of 350 consecutive patients were included in the study. There were 156 patients in the del Nido cardioplegia group and 194 patients in the blood cardioplegia group. Among the patient group, 74 (21.1%) patients developed acute kidney injury. The total acute kidney injury development rate was significantly higher in Group 2 (p=0.018). In multivariate logistic regression analysis, advanced age (OR 1.128; 95%CI 1.044–1.217; p=0.042), increased blood product use (OR 1.318; 95%CI 1.154–1.998; p=0.019), preoperative creatinine elevation (OR 2.434; 95%CI 1.655–4.639; p=0.005), and increased cardioplegia volume (OR 1.254; 95%CI 1.109–2.980; p=0.009) were independent predictors of acute kidney injury. CONCLUSION: With this study, we showed that the use of del Nido cardioplegia solution can reduce the incidence of acute kidney injury.Associação Médica Brasileira2021-09-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302021001001322Revista da Associação Médica Brasileira v.67 n.9 2021reponame:Revista da Associação Médica Brasileira (Online)instname:Associação Médica Brasileira (AMB)instacron:AMB10.1590/1806-9282.20210642info:eu-repo/semantics/openAccessKağan AS,AhmetEngin,MesutAmaç,BişarAydın,UfukEriş,CüneytAta,YusufTürk,Tamereng2021-11-17T00:00:00Zoai:scielo:S0104-42302021001001322Revistahttps://ramb.amb.org.br/ultimas-edicoes/#https://old.scielo.br/oai/scielo-oai.php||ramb@amb.org.br1806-92820104-4230opendoar:2021-11-17T00:00Revista da Associação Médica Brasileira (Online) - Associação Médica Brasileira (AMB)false
dc.title.none.fl_str_mv Effect of del nido cardioplegia use on kidney injury after coronary bypass operations
title Effect of del nido cardioplegia use on kidney injury after coronary bypass operations
spellingShingle Effect of del nido cardioplegia use on kidney injury after coronary bypass operations
Kağan AS,Ahmet
Coronary artery bypass surgery
Cardiopulmonary bypass
Kidney
Cardioplegia
title_short Effect of del nido cardioplegia use on kidney injury after coronary bypass operations
title_full Effect of del nido cardioplegia use on kidney injury after coronary bypass operations
title_fullStr Effect of del nido cardioplegia use on kidney injury after coronary bypass operations
title_full_unstemmed Effect of del nido cardioplegia use on kidney injury after coronary bypass operations
title_sort Effect of del nido cardioplegia use on kidney injury after coronary bypass operations
author Kağan AS,Ahmet
author_facet Kağan AS,Ahmet
Engin,Mesut
Amaç,Bişar
Aydın,Ufuk
Eriş,Cüneyt
Ata,Yusuf
Türk,Tamer
author_role author
author2 Engin,Mesut
Amaç,Bişar
Aydın,Ufuk
Eriş,Cüneyt
Ata,Yusuf
Türk,Tamer
author2_role author
author
author
author
author
author
dc.contributor.author.fl_str_mv Kağan AS,Ahmet
Engin,Mesut
Amaç,Bişar
Aydın,Ufuk
Eriş,Cüneyt
Ata,Yusuf
Türk,Tamer
dc.subject.por.fl_str_mv Coronary artery bypass surgery
Cardiopulmonary bypass
Kidney
Cardioplegia
topic Coronary artery bypass surgery
Cardiopulmonary bypass
Kidney
Cardioplegia
description SUMMARY OBJECTIVE: After cardiac surgery, acute kidney injury is observed at a rate of 5–30%, and the second most common cause of acute kidney injury in intensive care units is cardiac surgery. In this study, we aimed to investigate the effect of del Nido cardioplegia solution use on postoperative acute kidney injury development in patients who underwent coronary artery bypass grafting operation with cardiopulmonary bypass. METHODS: Consecutive patients who underwent an elective coronary artery bypass grafting operation with cardiopulmonary bypass in our clinic between March 15, 2019, and March 15, 2020, were included in the study retrospectively. The patients were divided into two groups as those who received del Nido cardioplegia solution (Group 1) and blood cardioplegia (Group 2), and factors affecting the development of renal failure were examined. RESULTS: A total of 350 consecutive patients were included in the study. There were 156 patients in the del Nido cardioplegia group and 194 patients in the blood cardioplegia group. Among the patient group, 74 (21.1%) patients developed acute kidney injury. The total acute kidney injury development rate was significantly higher in Group 2 (p=0.018). In multivariate logistic regression analysis, advanced age (OR 1.128; 95%CI 1.044–1.217; p=0.042), increased blood product use (OR 1.318; 95%CI 1.154–1.998; p=0.019), preoperative creatinine elevation (OR 2.434; 95%CI 1.655–4.639; p=0.005), and increased cardioplegia volume (OR 1.254; 95%CI 1.109–2.980; p=0.009) were independent predictors of acute kidney injury. CONCLUSION: With this study, we showed that the use of del Nido cardioplegia solution can reduce the incidence of acute kidney injury.
publishDate 2021
dc.date.none.fl_str_mv 2021-09-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302021001001322
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302021001001322
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1590/1806-9282.20210642
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Associação Médica Brasileira
publisher.none.fl_str_mv Associação Médica Brasileira
dc.source.none.fl_str_mv Revista da Associação Médica Brasileira v.67 n.9 2021
reponame:Revista da Associação Médica Brasileira (Online)
instname:Associação Médica Brasileira (AMB)
instacron:AMB
instname_str Associação Médica Brasileira (AMB)
instacron_str AMB
institution AMB
reponame_str Revista da Associação Médica Brasileira (Online)
collection Revista da Associação Médica Brasileira (Online)
repository.name.fl_str_mv Revista da Associação Médica Brasileira (Online) - Associação Médica Brasileira (AMB)
repository.mail.fl_str_mv ||ramb@amb.org.br
_version_ 1754212836819599360